The evolving paradigm of hyperglycemia and critical illness

Chest

Volumn 126, Issue 3, 2004, Pages 674-676

  Chinsky, Kenneth ^a,b,c  

^a Chest Diseases ot Northwestern PA ^*

^b Chest Diseases of Northwestern PA   (United States)

^c Chest Diseases of Northwestern Pennsylvania   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ACUTE HEART INFARCTION; CRITICAL ILLNESS; DISEASE ASSOCIATION; EDITORIAL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE; MEDICAL LITERATURE; MORBIDITY; MORTALITY; PATHOGENESIS; PATHOPHYSIOLOGY; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; WOUND INFECTION;

EID: 4544355987     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.3.674     Document Type: Editorial

References (15)

1. Capes S, Hunt D, Malmberg K, et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355:773-778
2. Furnary A, Gao G, Grunkeimer GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:1007-1021
3. Pomposelli J, Baxter J, Babineau T, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998; 22:77-81
4. Capes S, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2000; 31:183-192
5. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
6. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-1478
7. Goldberg PA, Inzucchi SE. Critical issues in endocrinology. Clin Chest Med 2003; 24:583-606
8. Van den Berghe G, Wouters R, Weekers F, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366
9. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047
10. Inzucchi SE, Goldberg PA, Dziura JD, et al. Risk factors for poor glycemic control in a medical intensive care unit. Paper presented at: American Diabetes Association 63rd Scientific Sessions; June 13-17, 2003; New Orleans, LA
11. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
12. Annane D, Melchior JC. Hormone replacement therapy for the critically ill. Crit Care Med 2003; 31:634-635
13. Van den Berghe G, Bouillon R. Optimal control of glycemia among critically ill patients [response by Finney SJ, Evans TW] [letter]. JAMA 2004; 291:1198-1199
14. Meier JJ, Weyhe D, Michaely M, et al. Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients wiht type 2 diabetes. Crit Care Med 2004; 32:848-851
15. American College of Endocrinology. Position statement on inpatient diabetes and metabolic control. Endocr Pract 2004; 10:77-82